newsfilter
← Latest News
ACCESS Newswire·

Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership

Milestone payment reflects continued progress under strategic research collaboration addressing high-need patient populationsFDA clearance of IND application triggered a US$ 5 m milestone payment to Evotec HAMBURG, DE /